Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients

Stopped Independent biostatistician recommended early termination of the trial due to low probability of success.

Conditions

• Health Care Associated Pneumonia
• Osteomyelitis/Septic Arthritis
• Endocarditis
• Bacteremia
• Acute Bacterial Skin and Skin Structure Infections

Interventions

• DRUG: Vancomycin
• DRUG: Ceftaroline
• DRUG: Daptomycin
• DRUG: Linezolid

Sponsor

Henry Ford Health System